Patent · US Active

Tablet compositions

US11389454B2 · kind B2 · utility

0Cited by

9References

4Claims

0Family size

Assignees

CELGENE CORPORATION · US
Servier Pharmaceuticals LLC · US

Inventors

Sreenivas S. Bhat · Kendall Park, US
Scott Burnside · Wilmington, US
Darshan Parikh · Bound Brook, US
Chong-Hui Gu · Newton, US
Syed Altaf · Mountain View, US

Key dates

Filing date	Sep 6, 2017
Grant date	Jul 19, 2022
Priority date	—
Expiry date	Sep 6, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein is a tablet comprising 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.